A. Conway

发表

Determinants and Outcomes of Late Presentation of HIV Infection in Migrants in Catalonia, Spain: PISCIS Cohort 2004–2016

A. Esteve, J. Casabona, A. Conway, 2018, Journal of Immigrant and Minority Health.

Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action

Piotr Wysocki, D. Staneková, J. Casabona, 2021, BMC Infectious Diseases.

Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment.

M. Alavi, V. Wiseman, G. Dore, 2022, Drug and alcohol dependence.

Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.

J. Ward, L. Degenhardt, G. Fontaine, 2022, The lancet. Gastroenterology & hepatology.

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

P. Read, G. Dore, J. Grebely, 2022, Viruses.

People engaged in opioid agonist treatment as a counterpublic during the COVID‐19 pandemic in Australia: A qualitative study

C. Treloar, J. Grebely, A. Conway, 2022, Drug and alcohol review.

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study

M. Alavi, P. Read, A. Milat, 2022, Viruses.

The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018

J. Casabona, M. Meroño, L. Fernández-López, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.

J. Ward, G. Dore, P. Vickerman, 2022, The International journal on drug policy.

Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.

M. Alavi, P. Read, G. Dore, 2022, The International journal on drug policy.

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.

M. Alavi, P. Read, A. Milat, 2022, The International journal on drug policy.

Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.

P. Read, G. Dore, J. Grebely, 2023, The International journal on drug policy.

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic

G. Dore, L. Degenhardt, C. Treloar, 2023, International Journal of Drug Policy.

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study

C. Treloar, J. Grebely, A. Conway, 2023, Implementation Science.